30 related articles for article (PubMed ID: 15853798)
1. Involvement of kinesin family member 2C/mitotic centromere-associated kinesin overexpression in mammary carcinogenesis.
Shimo A; Tanikawa C; Nishidate T; Lin ML; Matsuda K; Park JH; Ueki T; Ohta T; Hirata K; Fukuda M; Nakamura Y; Katagiri T
Cancer Sci; 2008 Jan; 99(1):62-70. PubMed ID: 17944972
[TBL] [Abstract][Full Text] [Related]
2. Mitotic Centromere-Associated Kinesin (MCAK/KIF2C) Regulates Cell Migration and Invasion by Modulating Microtubule Dynamics and Focal Adhesion Turnover.
Moon HH; Kreis NN; Friemel A; Roth S; Schulte D; Solbach C; Louwen F; Yuan J; Ritter A
Cancers (Basel); 2021 Nov; 13(22):. PubMed ID: 34830827
[TBL] [Abstract][Full Text] [Related]
3. MCAK Inhibitors Induce Aneuploidy in Triple-Negative Breast Cancer Models.
Smith JC; Husted S; Pilrose J; Ems-McClung SC; Stout JR; Carpenter RL; Walczak CE
Cancers (Basel); 2023 Jun; 15(13):. PubMed ID: 37444419
[TBL] [Abstract][Full Text] [Related]
4. The role of kinesin family members in hepatobiliary carcinomas: from bench to bedside.
Zhao K; Li X; Feng Y; Wang J; Yao W
Biomark Res; 2024 Mar; 12(1):30. PubMed ID: 38433242
[TBL] [Abstract][Full Text] [Related]
5. A Multimodal Molecular Imaging Study Evaluates Pharmacological Alteration of the Tumor Microenvironment to Improve Radiation Response.
Takakusagi Y; Naz S; Takakusagi K; Ishima M; Murata H; Ohta K; Miura M; Sugawara F; Sakaguchi K; Kishimoto S; Munasinghe JP; Mitchell JB; Krishna MC
Cancer Res; 2018 Dec; 78(24):6828-6837. PubMed ID: 30301838
[TBL] [Abstract][Full Text] [Related]
6. KIF-2C expression is correlated with poor prognosis of operable esophageal squamous cell carcinoma male patients.
Duan H; Zhang X; Wang FX; Cai MY; Ma GW; Yang H; Fu JH; Tan ZH; Fu XY; Ma QL; Wang XY; Lin P
Oncotarget; 2016 Dec; 7(49):80493-80507. PubMed ID: 27563815
[TBL] [Abstract][Full Text] [Related]
7. Total synthesis and structure-activity relationship of glycoglycerolipids from marine organisms.
Zhang J; Li C; Yu G; Guan H
Mar Drugs; 2014 Jun; 12(6):3634-59. PubMed ID: 24945415
[TBL] [Abstract][Full Text] [Related]
8. Signaling-dependent phosphorylation of mitotic centromere-associated kinesin regulates microtubule depolymerization and its centrosomal localization.
Pakala SB; Nair VS; Reddy SD; Kumar R
J Biol Chem; 2012 Nov; 287(48):40560-9. PubMed ID: 23055517
[TBL] [Abstract][Full Text] [Related]
9. Kinesins and cancer.
Rath O; Kozielski F
Nat Rev Cancer; 2012 Jul; 12(8):527-39. PubMed ID: 22825217
[TBL] [Abstract][Full Text] [Related]
10. Evaluation of activity and combination strategies with the microtubule-targeting drug sagopilone in breast cancer cell lines.
Eschenbrenner J; Winsel S; Hammer S; Sommer A; Mittelstaedt K; Drosch M; Klar U; Sachse C; Hannus M; Seidel M; Weiss B; Merz C; Siemeister G; Hoffmann J
Front Oncol; 2011; 1():44. PubMed ID: 22649765
[TBL] [Abstract][Full Text] [Related]
11. Mitotic centromere-associated kinesin (MCAK): a potential cancer drug target.
Sanhaji M; Friel CT; Wordeman L; Louwen F; Yuan J
Oncotarget; 2011 Dec; 2(12):935-47. PubMed ID: 22249213
[TBL] [Abstract][Full Text] [Related]
12. Cyclosporin A associated helicase-like protein facilitates the association of hepatitis C virus RNA polymerase with its cellular cyclophilin B.
Morohashi K; Sahara H; Watashi K; Iwabata K; Sunoki T; Kuramochi K; Takakusagi K; Miyashita H; Sato N; Tanabe A; Shimotohno K; Kobayashi S; Sakaguchi K; Sugawara F
PLoS One; 2011 Apr; 6(4):e18285. PubMed ID: 21559518
[TBL] [Abstract][Full Text] [Related]
13. Clinicopathological and biological significance of mitotic centromere-associated kinesin overexpression in human gastric cancer.
Nakamura Y; Tanaka F; Haraguchi N; Mimori K; Matsumoto T; Inoue H; Yanaga K; Mori M
Br J Cancer; 2007 Aug; 97(4):543-9. PubMed ID: 17653072
[TBL] [Abstract][Full Text] [Related]
14. An emulsion of sulfoquinovosylacylglycerol with long-chain alkanes increases its permeability to tumor cells.
Aoki S; Ohta K; Matsumoto K; Sakai H; Abe M; Miura M; Sugawara F; Sakaguchi K
J Membr Biol; 2006; 213(1):11-8. PubMed ID: 17347779
[TBL] [Abstract][Full Text] [Related]
15. Mammalian mitotic centromere-associated kinesin (MCAK): a new molecular target of sulfoquinovosylacylglycerols novel antitumor and immunosuppressive agents.
Aoki S; Ohta K; Yamazaki T; Sugawara F; Sakaguchi K
FEBS J; 2005 May; 272(9):2132-40. PubMed ID: 15853798
[TBL] [Abstract][Full Text] [Related]
16. C-terminus of mitotic centromere-associated kinesin (MCAK) inhibits its lattice-stimulated ATPase activity.
Moore A; Wordeman L
Biochem J; 2004 Oct; 383(Pt 2):227-35. PubMed ID: 15250824
[TBL] [Abstract][Full Text] [Related]
17. K-loop insertion restores microtubule depolymerizing activity of a "neckless" MCAK mutant.
Ovechkina Y; Wagenbach M; Wordeman L
J Cell Biol; 2002 Nov; 159(4):557-62. PubMed ID: 12446739
[TBL] [Abstract][Full Text] [Related]
18. Molecular dissection of the microtubule depolymerizing activity of mitotic centromere-associated kinesin.
Maney T; Wagenbach M; Wordeman L
J Biol Chem; 2001 Sep; 276(37):34753-8. PubMed ID: 11466324
[TBL] [Abstract][Full Text] [Related]
19. Mutations in the ATP-binding domain affect the subcellular distribution of mitotic centromere-associated kinesin (MCAK).
Wordeman L; Wagenbach M; Maney T
Cell Biol Int; 1999; 23(4):275-86. PubMed ID: 10600236
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
